Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would think getting relisted would be an urgent priority for any company. If that isn't an SEC requirement, I don't know what is. These recent tidbits of info are encouraging, but on the other hand I'm sick of waiting and holding these worthless shares. I've done a bit of legal research on my own and there's plenty of precedent for awarding punitive damages in cases like this against the company and its principals. That is, where there's a total and blatant disregard for the shareholder, as is clearly the case here with these 12 months of silence and stonewalling.
Thanks for the info Tom, good to know!
Still nothing. I think it's time to bring our class action, for compensatory and punitive damages. Should be a slam dunk. Does anyone know of a good area we can get together on this? That is, like a private room or something.
I'm even wondering if we will hear anything at all from them. Considering that so far they've shown nothing but a total disregard for us shareholders.
Good to know. Ok so now we have a date. After that no more Neville Chamberlaining.
So disappointing that January has come and gone without a peep. Now what? Hire lawyers? They're apparently banking on us to just go away.
Well said. I'm just wondering if we will get the Q4 report this month, seeing that the results as of 7/31 didn't come out until October 10th. If there's going to be a similar lag this time, then a separate communication to the shareholders before that would work. Already long overdue.
OK so a scenario here is that the new guys want to take part in IPO riches, and to get the old guys to agree, the oldies would need to get stock allotments that are at least equal to the value of their legacy ones, however that might be calculated given the lack of a market for them. Meanwhile us peons get totally screwed. This would surely be an open and shut case in our favor from a legal standpoint, in an ensuing class action. Plus I'd think such a blatant disregard would result in punitive damages being levied as well.
OK well that's something. They've actually had some good things happen since the delisting, and I'd reckon the share price would have been significantly higher by now.
The one thing that puzzles me is that Musick and the like must own a ton of the shares themselves. So you'd think it would be in their own best interest to get this cleared up ASAP.
Tom, about when do you think we can expect the 2021 report? Their results as of 7/31 were released on October 10, 2021, so with the same lag, that would mean around mid-March.
Ironically the 7/31 report is entitled “…. Financial Results of Operations and Shareholder Letter”, but of course it totally neglects addressing the delisting at all. Instead, as you pointed out, they tout a possible IPO:
“The company has commenced discussions with various investors and investment
banks on the prospects of going public with an institutional sponsored IPO on
the NASDQ or New York stock exchange. See the company's corporate presentation
here: https://www.vitrobiopharma.com/pages/e vents-presentations.”
Just dismissing us altogether. It certainly doesn’t look good.
Tom, can't say I blame ya. The wall of silence from them has been tough to take and shows a disregard for all of us. This community here has been a helpful place for us in these circumstances, not least as a way of validation and emotional support, but I agree that there is only so much speculation one can do in the complete absence of any facts. Anyways, thanks so much for all of your valuable and insightful contributions to this board. Good luck to all.... sure sounds like we're gonna need it!
Hi Tom, did you ever hear back from them?
It really has been a long wait, with no real reassurances from them. For them to say "in and around" Q4 gives them some wiggle room, of course. Q1 would qualify under that language. It's been frustrating for sure.
Thanks for this Tom, and for all of your contributions to this board. Seems like there's been some news lately on the positive side. We might well see a pop once trading is up and running again. All's I know is, I'm just glad that I'm not on the outside looking in. Gotta be tough as a trader/investor to see news and not be able to do anything about it.
Tom, yes, much appreciated. I just wish they would have thrown in something in the "About" section (or do a separate news release) on the status of the relisting, if it is ever even supposed to happen. Difficult to be kept in the dark like this no? There's been radio silence for way too long.
Tom, for sure. We’ve been in limbo for a long time now. It’d be nice to get an ETA from them, at the very least.
That certainly makes sense. Plus they presumably own a bunch of shares themselves.
With the announcement of good news like that, I’m disappointed that they didn’t give an update on the relisting. Even if it was something like, “We continue to make progress towards getting our stock relisted”. Is there any scenario where they can choose not to go that route and leave us holding the bag?
Nice find Tom, that’s great news. I think you’re right as to why they’re not putting out a news release. Would be kind of surreal to give a “shareholder update” while we’re still in limbo. On the strength of this and other developments, such as the impending return of medical tourism that you posted about before, I think the share price might well spike once we get re-listed. One would think that they should be more motivated than ever to get their house in order on that score.
Great find Tom. Very encouraging. Yes it is indeed anecdotal but obviously still significant. Along similar lines, the company did have that one COVID patient last summer who reportedly made an amazing recovery thanks to VB's treatment.
PS That user “Blue and Black Blood” said he sold his shares a few months ago, so it’s not surprising he’d be negative about VB’s prospects. Of course, even if he did want to get back in, he can’t, so that’s gotta be doubly frustrating, especially if positive news continues to come in. All’s I’m saying is, consider the source!
Good to see. Thanks for the insights as always, Tom.
One thing that I find surprising -- and that's actually really good -- is that the daily volume has been so low. The 10 day average is about 2 million shares, which means only $80,000 a day (at 4 cents per). Meanwhile management cited Tesla in its tweet earlier this year. If more news comes out, tying us to Tesla (as well as the other EV companies), then the volume should spike dramatically.
Great finds! I think this stock is poised to take off, once it becomes more known. I thought their tweet earlier this year mentioning Tesla was pretty telling, considering how conservative the management has been about doing PR. https://twitter.com/appliedminerals?lang=en. And then there's this news item: https://www.nytimes.com/2021/03/15/business/volkswagen-electric-cars-tesla.html. Needless to say, all of these batteries will need halloysite.
Thanks Tom, that's good to know. Glad it hasn't just been radio silence. The company did have that one COVID patient last summer who reportedly made an amazing recovery thanks to VODG's treatment, so you'd think they'd want to continue pursuing that path as well.
Alright now we are 3. Tom, are you out there? Who else?
Any thoughts on MESO's bad news and how it could affect VODG, assuming it relists?
OK let’s keep it here then. You’re right, we’re in wait-and-see mode right now. Hopefully there will be some kind of communication from them sooner rather than later.
PS My handle on the Yahoo board is fontana
Interesting. Thanks for posting this. If anyone wants to discuss VODG matters on the Yahoo board, I posted a message there just now on the MESO board (referring to VODG). Feel free to reply under it so we can carry on the dialogue. GLTA
Thanks EEE. To put this in context, see: "Globalstar embraces LTE in revamped terrestrial communications plan".
http://spacenews.com/65025-2/?utm_content=buffere506b&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer#sthash.v4oQhTU5.dpuf
Here's the video of the Bloomberg piece from late Thursday afternoon on how GSAT spectrum is seriously undervalued and may appeal to Amazon, Google, Facebook, etc.
https://www.bloomberg.com/news/videos/2017-05-18/solus-ceo-says-gsat-spectrum-may-appeal-to-amazon-video
I'm pleased to report that the person shorting my shares has finally capitulated. He/she/it borrowed my shares at $1.46 a few months back at 10% and tenaciously held on as the stock took off. I tried to shake him but couldn't, and was wondering who the heck this was that was shorting something with such upside potential as GSAT when there seemed to be so many other better and safer investments out there to be had. And at 10% to boot! But just now he finally gave up, at a huge loss. Wise move. Maybe now he's going to join us longs. If so, welcome, whoever you are. No hard feelings. In the meantime, other shorts reading this should take notice. Looks like your cohorts are heading to the exits. Get out while you still can, yeah?
Odeon's latest take. The analyst notes that there could be a big, positive surprise on the international side. https://www.streetinsider.com/dr/news.php?id=12712560&gfv=1
A new ETF tailor-made for GSAT? A new ETF, the Active Alts Contrarian ETF (SQZZ, US), made its debut yesterday. It only invests in stocks that it sees as likely candidates for a short squeeze. One of its holdings is Weight Watchers, whose shares in late February popped more than 50% over a three-day period in the wake of its quarterly results, in what was clearly a short squeeze. One wonders if the ETF has scooped up a load of GSAT, or is looking to do so, for obvious reasons.
Sprint's parent company in the news.
A Titan's Pledge Will Test Bankers
The New York Times
LANDON THOMAS Jr.
11 January 2017
Many business titans have made the trek to Trump Tower for a private audience with Donald J. Trump since he was elected president, but none have made a bigger splash than Masayoshi Son, the billionaire telecommunications entrepreneur.
''Ladies and gentlemen, this is Masa of SoftBank of Japan and he has just agreed to invest $50 billion in the U.S. and 50,000 jobs,'' Mr. Trump said, wrapping an arm around the beaming Mr. Son last month.
That pledge suggested a wave of money pouring into technology start-ups in Silicon Valley. And it is part of a hugely ambitious $100 billion investment fund -- the SoftBank Vision Fund -- that Mr. Son announced in October.
Yet bankers who are advising the SoftBank fund say that more than three-quarters of the fund's resources will be directed toward larger investments in private and public markets, rather than into start-ups.
That could mean swooping in to grab a piece of an undervalued technology company trading on the stock exchange or doing a large-scale private equity deal.
There's no way this will be bad news. Back in November, on the last earnings call, Jay said: "When the proceeding finishes, we look forward to holding a separate call dedicated to the approval's implications for our business."
The shorting funds are going to try to keep the stock down till the end of the year in an attempt to make their yearly performance numbers look better. After January 1st, and as the conference call approaches, this thing will start to take off again IMHO.
Here's what Jay said on the last earnings call in November:
"When the proceeding finishes, we look forward to holding a separate call dedicated to the approval's implications for our business."